We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Automated AI-Powered Microscope Accurately Identifies Malaria Parasites in Blood Samples

By LabMedica International staff writers
Posted on 11 Aug 2023

Every year, over 200 million individuals contract malaria, with more than half a million of these cases resulting in fatalities. More...

The World Health Organization advocates for the use of parasite-based diagnosis prior to commencing treatment for the infectious disease caused by Plasmodium parasites. Various diagnostic techniques are available, including conventional light microscopy, rapid diagnostic tests, and PCR. Nevertheless, the established benchmark for malaria diagnosis is manual light microscopy, where a specialist examines blood samples under a microscope to verify the presence of malaria parasites. However, the result accuracy is heavily dependent on the expertise of the microscopist and can be affected by fatigue caused by workloads among the professionals conducting the tests.

Due to the demanding nature of traditional diagnosis and the high workload, an international team of researchers undertook an investigation into the feasibility of employing a novel system that combines an automated scanning microscope with artificial intelligence (AI) for clinical diagnosis. The results indicated that this system identified malaria parasites with almost the same accuracy as experienced microscopists following standard diagnostic procedures. This advancement holds the potential to ease the burden of microscopists and increase the manageable patient caseload.

Researchers at The Hospital for Tropical Diseases at UCLH (London, UK) tested a fully automated malaria diagnostic system comprising both hardware and software components. The automated microscopy platform scans blood samples, and algorithms for malaria detection process the images to detect the presence and quantity of parasites. The researchers analyzed more than 1,200 blood samples from travelers who had returned to the UK from regions where malaria is prevalent. The study evaluated the accuracy of the AI-microscope system in a true clinical setting under ideal conditions.

The researchers compared the results obtained from both manual light microscopy and the AI-microscope system. Manually, 113 samples were identified as having malaria parasites, whereas the AI system accurately detected 99 positive samples, resulting in an 88% accuracy rate. Despite this commendable accuracy rate, the automated system also produced false positives, indicating 122 samples as positive when they were not, potentially leading to unnecessary administration of anti-malarial drugs to patients.

“At an 88% diagnostic accuracy rate relative to microscopists, the AI system identified malaria parasites almost, though not quite, as well as experts,” said Dr. Roxanne Rees-Channer, a researcher at The Hospital for Tropical Diseases at UCLH. “This level of performance in a clinical setting is a major achievement for AI algorithms targeting malaria. It indicates that the system can indeed be a clinically useful tool for malaria diagnosis in appropriate settings.”

Related Links:
UCLH 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automatic CLIA Analyzer
Shine i6000
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.